These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15233951)
1. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Uchida H; Tanaka T; Sasaki K; Kato K; Dehari H; Ito Y; Kobune M; Miyagishi M; Taira K; Tahara H; Hamada H Mol Ther; 2004 Jul; 10(1):162-71. PubMed ID: 15233951 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo. Wang L; Feng J; Da L; Li Y; Li Z; Zhao M Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):213-9. PubMed ID: 23296076 [TBL] [Abstract][Full Text] [Related]
3. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077 [TBL] [Abstract][Full Text] [Related]
4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Survivin by Adenovirus Vector Enhanced Paclitaxel-induced Apoptosis in Breast Cancer Cells. Tanaka T; Uchida H Anticancer Res; 2018 Jul; 38(7):4281-4288. PubMed ID: 29970562 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells. Yang CT; Li JM; Weng HH; Li YC; Chen HC; Chen MF Cancer Gene Ther; 2010 Feb; 17(2):120-30. PubMed ID: 19730451 [TBL] [Abstract][Full Text] [Related]
7. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. Li QX; Zhao J; Liu JY; Jia LT; Huang HY; Xu YM; Zhang Y; Zhang R; Wang CJ; Yao LB; Chen SY; Yang AG Cancer Biol Ther; 2006 Jul; 5(7):860-6. PubMed ID: 16861916 [TBL] [Abstract][Full Text] [Related]
8. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma. Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663 [TBL] [Abstract][Full Text] [Related]
9. [Apoptosis of glioma cell line U251 induced by small interfering RNA targeting survivin]. Xu RX; Tu YY; Jiang XD; Feng JN; Huang J Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):398-401. PubMed ID: 16624736 [TBL] [Abstract][Full Text] [Related]
10. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo. Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665 [TBL] [Abstract][Full Text] [Related]
11. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. Hou JQ; He J; Wang XL; Wen DG; Chen ZX Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022 [TBL] [Abstract][Full Text] [Related]
12. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo. Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821 [TBL] [Abstract][Full Text] [Related]
13. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Chu L; Gu J; Sun L; Qian Q; Qian C; Liu X Gene Ther; 2008 Apr; 15(7):484-94. PubMed ID: 18239605 [TBL] [Abstract][Full Text] [Related]
14. [Effects of survivin small interfering RNA on biological behaviors of bladder cancer T24 cells]. Wang XL; Hou JQ; Wen DG; He J Ai Zheng; 2008 Mar; 27(3):253-7. PubMed ID: 18334113 [TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression. Wang R; Lin F; Wang X; Gao P; Dong K; Wei SH; Cheng SY; Zhang HZ Cancer Biol Ther; 2007 Aug; 6(8):1295-301. PubMed ID: 17712228 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy. Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502 [TBL] [Abstract][Full Text] [Related]
17. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
18. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo. Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of survivin expression by small interfering RNA suppresses proliferation of two human cancer cell lines. Guan HT; Xue XH; Wang XJ; Li A; Qin ZY Chin Med Sci J; 2006 Jun; 21(2):115-9. PubMed ID: 16845800 [TBL] [Abstract][Full Text] [Related]
20. MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway. Li Y; Zhang S; Wang Y; Peng J; Fang F; Yang X BMC Cancer; 2018 Dec; 18(1):1294. PubMed ID: 30594176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]